(WWJ) There’s a nationwide recall involving two popular children’s cough medicines.
Robitussin and Dimetapp have both been voluntarily recalled by the manufacturer, Glaxosmithkline, due to potential overdose risks.
The company says the wrong size dosing cups were included in the packages, and parents and caregivers could put too much medicine in the cup. The company said there are discrepancies between the graduations printed on the dosing cups and the indicated amounts to be administered.
The recall includes three lots of Children’s Robitussin Honey Cough and Chest Congestion and Children’s Dimetapp Cold and Cough, distributed to stores across the U.S. between February 5 and June 3, 2020.
The following products have been recalled:
Children's Robitussin® Honey Cough and Chest Congestion DM (4oz) - NDC 0031-8760-12
Lot: 02177 (Exp. Jan. 2022)
Lot: 02178 (Exp. Jan. 2022)
Children's Dimetapp® Cold and Cough (8oz) - NDC 0031-2234-19
Lot: CL8292 (Exp. Sep. 2021)
This image shows where to find these numbers on bottle and packaging.
Customers who bought the recalled medicine can return it at the place of purchase.
Symptoms of overdose of either product may include any of the following: impaired coordination; brain stimulation causing increase in energy, elevation in blood pressure, heart rate, and respiration; a lack of energy and enthusiasm; severe dizziness or drowsiness; slow heart rate; fainting; psychotic behavior; restlessness; seizure; decreased respiration; nausea; vomiting; constipation; diarrhea; abdominal pain; visual and hearing hallucinations; urinary retention. Contact a doctor if any of these occur.
As of the date of the recall announcement, GSK said they did not know of any overdose incident and had not nay consumer complaints regarding the incorrect dosing cups.
Consumers with questions regarding about this recall or to report an adverse experience should call 1-800-762-4675, during regular business hours.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report ONLINE HERE.
Regular Mail or Fax: Download the form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
LISTEN NOW on the RADIO.COM App
Follow RADIO.COM
Facebook | Twitter | Instagram